TAKEDA PHARMACEUTICAL CO LTD ORDINARY SH (OTCMKTS:TKPHF) on Focus After Report of Less Shorts

April 16, 2018 - By Vivian Currie

Takeda Pharmaceutical Company Limited (OTCMKTS:TKPHF) Logo

The stock of TAKEDA PHARMACEUTICAL CO LTD ORDINARY SH (OTCMKTS:TKPHF) registered a decrease of 15.17% in short interest. TKPHF’s total short interest was 757,500 shares in April as published by FINRA. Its down 15.17% from 893,000 shares, reported previously. With 200 shares average volume, it will take short sellers 3788 days to cover their TKPHF’s short positions. The short interest to TAKEDA PHARMACEUTICAL CO LTD ORDINARY SH’s float is 0.1%.

It closed at $46.135 lastly. It is down 0.00% since April 16, 2017 and is . It has underperformed by 11.55% the S&P500.

Takeda Pharmaceutical Company Limited engages in the research and development, manufacture, marketing, and sale of pharmaceutical products worldwide. The company has market cap of $36.17 billion. The firm operates in three divisions: Prescription Drug, Consumer Healthcare, and Other. It has a 20.4 P/E ratio. It offers prescription, OTC, and quasi-drugs; and reagents in various therapeutic areas, including oncology, gastroenterology, central nervous system, vaccines, and others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: